Genmab - ADR
News
Genmab A/S (NASDAQ:GMAB) Price Target Lowered to $50.00 at Truist Financial
Ticker Report Genmab A/S (NASDAQ:GMAB - Get Free Report) had its price objective reduced by equities research analysts at Truist Financial from $53.00 to $50.00 in a research note issued on Monday, Benzinga...\n more…
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Globe Newswire Company Announcement COPENHAGEN, Denmark; September 10, 2024 Genmab A/S (Nasdaq: GMAB) will increase its share capital by 11,729 shares as a consequence of the exercise of employee warrants. The...\n more…
Gallacher Capital Management LLC Buys 4,093 Shares of Genmab A/S (NASDAQ:GMAB)
Ticker Report Gallacher Capital Management LLC boosted its stake in Genmab A/S (NASDAQ:GMAB - Free Report) by 52.0% in the second quarter, according to the company in its most recent 13F filing with the Securities...\n more…
Allspring Global Investments Holdings LLC Buys 1,787 Shares of Genmab A/S (NASDAQ:GMAB)
Ticker Report Allspring Global Investments Holdings LLC grew its position in shares of Genmab A/S (NASDAQ:GMAB - Free Report) by 123.0% during the second quarter, according to its most recent filing with the...\n more…
Analysts Offer Predictions for Genmab A/S's Q3 2024 Earnings (NASDAQ:GMAB)
Ticker Report Genmab A/S (NASDAQ:GMAB - Free Report) - Research analysts at HC Wainwright lifted their Q3 2024 earnings estimates for Genmab A/S in a research report issued on Tuesday, August 27th. HC Wainwright...\n more…